Affiliation:
1. From the Departments of Bioengineering (A.C., M.L.C., H.L.Y., M.S.), Pathology (J.L.R., M.E.R.), and Orthopaedics and Sports Medicine (T.S.G., P.H.), University of Washington, Seattle, WA.
Abstract
Objective—
Osteoprotegerin (OPG) is a decoy receptor for the osteoclast differentiation factor receptor activator of NF-κB ligand. OPG regulates bone homeostasis, and its inactivation in mice results in severe osteoporosis. OPG deficiency in apolipoprotein E (ApoE)
−/−
mice results in increased atherosclerotic lesion size and calcification. Furthermore, receptor activator of NF-κB ligand enhances macrophage-dependent smooth muscle cell calcification in vitro. Here, we hypothesized that reconstitution of ApoE
−/−
OPG
−/−
mice with ApoE
−/−
OPG
+/+
bone marrow (BM) would be sufficient to rescue lesion progression and vascular calcification. Conversely, reconstitution of ApoE
−/−
OPG
+/+
mice with ApoE
−/−
OPG
−/−
BM may accelerate lesion progression and vascular calcification.
Approach and Results—
ApoE
−/−
OPG
−/−
mice transplanted with ApoE
−/−
OPG
+/+
BM developed smaller atherosclerotic lesions and deposited less calcium in the innominate artery than that of ApoE
−/−
OPG
−/−
mice transplanted with ApoE
−/−
OPG
−/−
BM. There were no differences in lesion size and calcification in ApoE
−/−
OPG
+/+
mice transplanted with BM from ApoE
−/−
OPG
−/−
or ApoE
−/−
OPG
+/+
mice. The large lesions observed in the ApoE
−/−
OPG
−/−
mice transplanted with OPG
−/−
BM were rich in chondrocyte-like cells, collagen, and proteoglycans. Importantly, the ApoE
−/−
OPG
−/−
mice transplanted with OPG
+/+
BM remained osteoporotic, and the ApoE
−/−
OPG
+/+
mice did not show signs of bone loss regardless of the type of BM received. In coculture experiments, macrophages and mesenchymal stem cells derived from ApoE
−/−
OPG
−/−
BM induced more vascular smooth muscle cell calcification than cells derived from ApoE
−/−
OPG
+/+
mice.
Conclusions—
These results indicate that OPG derived either from the BM or from the vessel wall is sufficient to slow down lesion progression and vascular calcification independent of bone turnover.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献